Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 10, 2017, Pages

  Radunovic, Aleksandar ^a   Annane, Djillali ^b   Rafiq, Muhammad K ^c   Brassington, Ruth ^d   Mustfa, Naveed ^e  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^e UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENT; AMYOTROPHIC LATERAL SCLEROSIS; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; CAUSE OF DEATH; DEGENERATIVE DISEASE; DISEASE DURATION; EUROPE; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; MEDIAN SURVIVAL TIME; MOTOR NEURON DISEASE; NONINVASIVE VENTILATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SHORT FORM 36; SYSTEMATIC REVIEW; THERAPY EFFECT; TRACHEOSTOMY; TREATMENT DURATION; WESTERN HEMISPHERE; COMPLICATION; DISEASE EXACERBATION; MORTALITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; SURVIVAL ANALYSIS; TIME FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; HUMANS; MOTOR NEURON DISEASE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 85030539154     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004427.pub4     Document Type: Review

References (87)

1. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurology 2006;5(2):140-7. [PUBMED: 16426990]2914423
2. Jackson CE, Rosenfeld J, Moore DH, Bryan WW, Barohn RJ, Wrench M, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. Journal of the Neurological Sciences 2001;191(1-2):75-8. [PUBMED: 11676995]2914425
3. Aboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H. Effect of non invasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Annals of Internal Medicine 1997;127(6):450-3. 2914427
4. Bach JR. Amyotrophic lateral sclerosis. Communication status and survival with ventilatory support. American Journal of Physical Medicine and Rehabilitation 1993;72(6):343-9. 2914429
5. Berlowitz DJ, Howard ME, Fiore JF Jr, Vander Hoorn S, O'Donoghue FJ, Westlake J, et al. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. Journal of Neurology, Neurosurgery & Psychiatry 2016;87(3):280-6. 6819147
6. Buhr-Schinner H, Laier-Groeneveld G, Criée CP. Amyotrophic lateral sclerosis and nasal mechanical ventilation. Medizinische Klinik (Munich) 1999;94(1 Spec No):102-4. 2914431
7. Cazzolli PA, Oppenheimer EA. Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation. Journal of the Neurological Sciences 1996;139(Suppl):123-8. 2914433
8. Cedarbaum JM, Stambler N. Disease status and use of ventilatory support by ALS patients. BDNF Study Group. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2001;2(1):19-22. 2914435
9. David WS, Bundlie SR, Mahdavi Z. Polysomnographic studies in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 1997;152(Suppl 1):S29-35. 2914437
10. Goulon M, Goulon-Goëau C. Amyotrophic lateral sclerosis and respiratory support [Sclérose latérale amyotrophique et assistance respiratoire]. Revue Neurologique 1989;145(4):293-8. 2914439
11. Jacobs TL, Brown DL, Baek J, Migda EM, Funckes T, Gruis KL. Trial of early noninvasive ventilation for ALS: a pilot placebo-controlled study. Neurology 2016;87(18):1878-83. 6819149
12. NCT00580593. Pilot placebo-controlled trial of early noninvasive ventilation for amyotrophic lateral sclerosis. clinicaltrials.gov/show/NCT00580593 (first received 16 July 2007). 6819150
13. Kamimoto K, Murakam N, Muroga T, Matsubara M, Yamamoto M. A comparative study between amyotrophic lateral sclerosis patients with and without mechanical ventilation. Clinical Neurology 1989;29(8):989-93. 2914441
14. Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. Journal of the Neurological Sciences 1999;164(1):82-8. 2914443
15. Lo Coco D, Marchese S, Pesco MC, La Bella V, Piccoli F, Lo Coco A. Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology 2006;67(5):761-5. 2914445
16. Lo Coco D, Marchese S, La Bella V, Piccoli T, Lo Coco A. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation. Chest 2007;132(1):64-9. 2914447
17. Lyall RA, Donaldson N, Fleming T, Wood C, Newsom-Davis I, Polkey MI, et al. A prospective study of quality of life in ALS patients treated with non-invasive ventilation. Neurology 2001;57(1):153-6. 2914449
18. Mustfa N, Walsh E, Bryant V, Lyall RA, Addington-Hall J, Goldstein LH, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology 2003;66(8):1211-7. 6819152
19. NCT00386464. Noninvasive ventilation in ALS patients with mild respiratory involvement. clinicaltrials.gov/show/NCT00386464 (first received 10 October 2006). 2914451
20. NCT00537446. Effect of noninvasive ventilation on lung function in amyotrophic lateral sclerosis. clinicaltrials.gov/show/NCT00537446 (first received 27 September 2007). 2914453
21. NCT00560287. Non-invasive ventilation in amyotrophic lateral sclerosis. clinicaltrials.gov/show/NCT00560287 (first received 16 November 2007). 2914455
22. Lee P. NIV in ALS [personal communication]. Email to: M Rafiq 15 June 2015. 2914457
23. NCT00958048. Effects of nocturnal non-invasive ventilation in patients with amyotrophic lateral sclerosis. clinicaltrials.gov/ct2/show/NCT00958048 (first received 8 February 2009. 2914458
24. NCT01363882. Polysomnography-directed noninvasive ventilation in amyotrophic lateral sclerosis (ALS). clinicaltrials.gov/show/NCT01363882 (first received 28 March 2011). 2914460
25. Gonzalez N, Prats E, Rodriguez-Gonzalez MJ, Marti S, Lujan M, Povedano MP. Effects of early non invasive ventilation on pulmonary function in ALS patients: preliminary results of a randomized controlled trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2014;15:101. 6819153
26. NCT01641965. Impact of early non invasive ventilation in amyotrophic lateral sclerosis (ALS) patients. clinicaltrials.gov/ct2/show/NCT01641965 (first received 13 July 2012). 2914462
27. NCT01746381. Non-invasive ventilation in amyotrophic lateral sclerosis (ALS) using the iVAPS mode. clinicaltrials.gov/ct2/show/NCT01746381 (first received 4 December 2012). 2914464
28. NCT02537132. New perspectives of adaptation to NIV in ALS. clinicaltrials.gov/show/NCT02537132 (first received 28 August 2015). 2914466
29. Newsom-Davis IC, Lyall RA, Leigh PN, Moxham J, Goldstein LH. The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in ALS: a prospective study. Journal of Neurology, Neurosurgery & Psychiatry 2001;71(4):482-7. 2914468
30. Perez T, Salachas F. Early nasal ventilation in amyotrophic lateral sclerosis: impact on survival and quality of life (the VNP-SLA study). Revue des Maladies Respiratoires 2003;20(4):589-98. 2914470
31. Pinto AC, Evangelista T, Carvalho M, Alves MA, Sales Luís ML. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. Journal of the Neurological Sciences 1995;129(Suppl):19-26. 2914472
32. Pinto AC, Alves M, Nogueira A, Evangelista T, Carvalho J, Coelho A, et al. Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?. Journal of the Neurological Sciences 1999;169(1-2):69-75. 2914474
33. Pinto A, de Carvalho M, Evangelista T, Lopes A, Sales-Luis L. Nocturnal pulse oximetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2003;4(1):31-5. 2914476
34. Saito T. Mechanical ventilation for amyotrophic lateral sclerosis - making a comparison between hospital and home care. Rinsho Shinkeigaku (Clinical Neurology) 1999;39(1):70-1. 2914478
35. Shoesmith CL, Findlater K, Rowe A, Strong MJ. Prognosis of amyotrophic lateral sclerosis with respiratory onset. Journal of Neurology, Neurosurgery & Psychiatry 2007;78(6):629-31. 2914480
36. Sivak ED, Gipson WT, Hanson MR. Long-term management of respiratory failure in amyotrophic lateral sclerosis. Annals of Neurology 1982;12(1):18-23. 2914482
37. Winterholler MG, Erbguth FJ, Hecht MJ, Heuss D, Neundörfer B. Survival with artificial respiration at home. An open, prospective study on home ventilation for neuromuscular diseases, in particular, the situation of ALS patients. Nervenarzt 2001;72(4):293-301. 2914484
38. Aboussouan LS, Khan SU, Banerjee M, Arroligan AC, Mitsumoto H. Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle & Nerve 2001;24(3):403-9.
39. The ALS CNTF (ACTS) Phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Archives of Neurology 1996;53(2):141-7.
40. Annane D, Orlikowski D, Chevret S. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD001941.pub3]
41. Bach JR. Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids. Archives of Physical Medicine and Rehabilitation 1995;76(9):828-32.
42. Bach JR. Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory aids. Chest 2002;122(1):92-8.
43. Baxter SK, Baird WO, Thompson S, Bianchi SM, Walters SJ, Lee E, et al. The initiation of non-invasive ventilation for patients with motor neuron disease: patient and carer perceptions of obstacles and outcomes. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013;14(2):105-10.
44. Baxter SK, Baird WO, Thompson S, Bianchi SM, Walters SJ, Lee E, et al. The use of non-invasive ventilation at end of life in patients with motor neurone disease: a qualitative exploration of family carer and health professional experiences. Palliative Medicine 2013;27(6):516-23.
45. Baxter SK, Baird WO, Thompson S, Bianchi SM, Walters SJ, Lee E, et al. The impact on the family carer of motor neurone disease and intervention with noninvasive ventilation. Journal of Palliative Medicine 2013;16(12):1602-9.
46. Borasio GD, Gelinas DF, Yanagisawa N. Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective. Journal of Neurology 1998;245(Suppl 2):S7-12.
47. Borasio GD, Shaw PJ, Hardiman, Ludolph AC, Sales Luis M, Silani V. Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2001;2(3):159-64.
48. Bourke SC, Shaw PJ, Gibson GJ. Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS. Neurology 2001;57(11):2040-4.
49. Bourke SC, Williams TL, Bullock RE, Gibson GJ, Shaw PJ. Non-invasive ventilation in motor neuron disease: current UK practice. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2002;3(3):145-9.
50. Bradley WG, Anderson F, Bromberg M, Gutmann C, Harati Y, Ross M, et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology 2001;57(3):500-4.
51. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. Journal of Neurological Sciences 1994;124(Suppl):96-107.
52. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000;1(5):293-9.
53. Carratù P, Spicuzza L, Cassano A, Maniscalco M, Gadaleta F, Lacedonia D, et al. Early treatment with noninvasive positive pressure ventilation prolongs survival in amyotrophic lateral sclerosis patients with nocturnal respiratory insufficiency. Orphanet Journal of Rare Diseases 2009;4(10). [DOI: 10.1186/1750-1172-4-10]
54. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences 1999;169(1-2):13-21.
55. Chaudri MB, Liu C, Watson L, Jefferson D, Kinnear WJ. Sniff nasal pressure as a marker of respiratory function in motor neuron disease. European Respiratory Journal 2000;15(3):539-42.
56. Chio A, Silani V, Italian ALS Study Group. Amyotrophic lateral sclerosis in Italy: a nationwide study in neurological centers. Journal of the Neurological Sciences 2001;191(1-2):145-50.
57. Fitting JW, Paillex R, Hirt L, Aebischer P, Schluep M. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Annals of Neurology 1999;46(6):887-93.
58. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model of survival prediction. Brain 1995;118(Pt 3):707-19.
59. Hayashi H. Ventilatory support: Japanese experience. Journal of the Neurological Sciences 1997;152(Suppl 1):S97-100.
60. Hein H, Schucher B, Kirsten D, Magnussen H. Prospective study of the quality of life in intermittent self-ventilation. Medizinische Klinik 1997;92(Suppl 1):93-4.
61. Hein H, Schucher B, Magnussen H. Intermittent assisted ventilation in neuromuscular diseases: course and quality of life. Pneumonologie 1999;53 Suppl 2:S89-90. [MEDLINE: 20079874]
62. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
63. ISRCTN76330611. Sleep disordered breathing and the impact of nocturnal non-invasive ventilatory support on quality of life in motor neurone disease. www.isrctn.com/ISRCTN76330611 (accesssed 23 June 2016). [DOI: 10.1186/ISRCTN76330611]
64. Jones U, Enright S, Busse M. Management of respiratory problems in people with neurodegenerative conditions: a narrative review. Physiotherapy 2012;98(1):1-12.
65. Kawata A, Mizoguchi K, Hayashi H. A nationwide survey of ALS patients on tracheostomy positive pressure ventilation (TPPV) who developed a totally locked-in state (TLS) in Japan. Rinsho Shinkeigaku 2008;48(7):476-80.
66. Lechtzin N, Wiener CM, Shade DM, Clawson L, Diette GB. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest 2002;121(2):436-42.
67. Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001;124(Pt 10):2000-13.
68. Mehta S, Hill NS. Noninvasive ventilation. American Journal of Respiratory and Critical Care Medicine 2001;163(2):540-77.
69. Melo J, Homma A, Iturriaga E, Frierson L, Amato A, Anzueto A, et al. Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposal of a pulmonary protocol. Journal of the Neurological Sciences 1999;169(1-2):114-7.
70. Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD001447.pub3]
71. Moss AH, Casey P, Stocking CB, Roos RP, Brooks BR, Siegler M. Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes. Neurology 1993;43(2):438-43.
72. Moss AH, Oppenheimer EA, Casey P, Cazzolli PA, Roose RP, Stocking CB, et al. Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation: advance care planning and outcomes. Chest 1996;110(1):249-55.
73. National Institute for Health and Care Excellence. Motor neurone disease: non-invasive ventilation. London: National Institute for Health and Care Excellence; July 2010. Clinical guideline [CG105].
74. Norris FH, Calanchini PR, Fallat R, Panchari S, Jewett BJ. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974;24(8):721-8.
75. O'Neill CL, Williams TL, Peel ET, McDermott CJ, Shaw PJ, Gibson GJ, et al. Non-invasive ventilation in motor neuron disease: an update of current UK practice. Journal of Neurology, Neurosurgery & Psychiatry 2012;83(4):371-6.
76. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
77. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
78. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998;50(1):66-72.
79. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
80. Turner MR, Parton MJ, Shaw CE, Leigh PN, Al-Chalabi A. Prolonged survival in motor neuron disease: a descriptive study of the King's Database 1990-2000. Journal of Neurology, Neurosurgery & Psychiatry 2003;74(7):995-7.
81. Varrato J, Siderwof A, Damiano P, Gregory S, Feinberg D, McCluskey L. Postural change of forced vital capacity predicts some respiratory symptoms in ALS. Neurology 2001;57(2):357-9.
82. Vitacca M, Clini E, Facchetti D, Pagani M, Polani M, Porta R, et al. Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis. European Respiratory Journal 1997;10(7):1614-21.
83. Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. Journal of the Neurological Sciences 2001;191(1-2):3-9.
84. Yamaguchi M, Hideaki H, Kuniko H. Ventilatory support in Japan: a new life with ALS and a positive approach to living with the disease. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2001;2(4):209-11.
85. Leigh PN, Annane D, Jewitt K, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD004427]
86. Radunovic A, Annane D, Jewitt K, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD004427.pub2]
87. Radunovic A, Annane D, Rafiq MK, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD004427.pub3]